Indeed, we found higher gene expression of ACE2 and CD209 in upper airway cells of COVID-19 ARIs compared to non-viral ARIs, and CD209 plasma protein expression was correlated COVID-19 risk and severity. The gene discussed is ACE2; the disease is COVID-19.